Short answer · Medically reviewed summary · Last updated: 2026-05-08
Pars planitis is an intermediate uveitis characterized by inflammation in the pars plana region of the eye, typically treated with corticosteroids to reduce inflammation and preserve vision. Treatment is highly personalized, often beginning with local or systemic steroids and advancing to immunosuppressive therapies if the condition is chronic or sight-threatening. What are the first-line treatments for Pars Planitis? The primary goal in treating Pars Planitis is to control ocular inflammation and prevent complications such as cystoid macular edema.
What are the best treatments for Pars Planitis?
Treatments for Pars Planitis: what real patients say works for them, alongside a medically reviewed overview citing sources like NIH GARD and Orphanet.
Pars planitis is an intermediate uveitis characterized by inflammation in the pars plana region of the eye, typically treated with corticosteroids to reduce inflammation and preserve vision. Treatment is highly personalized, often beginning with local or systemic steroids and advancing to immunosuppressive therapies if the condition is chronic or sight-threatening.
What are the first-line treatments for Pars Planitis?
The primary goal in treating Pars Planitis is to control ocular inflammation and prevent complications such as cystoid macular edema. Most clinicians start with topical or periocular corticosteroid injections (e.g., triamcinolone acetonide) to target the inflammation directly. If the Pars Planitis is bilateral or resistant to local therapy, systemic corticosteroids (prednisone) are often initiated as a bridge to long-term management.
What medications are used for long-term management?
When Pars Planitis becomes chronic, clinicians often transition patients to "steroid-sparing" agents to avoid the side effects of long-term prednisone use. These medications include:
- Antimetabolites: Methotrexate or Mycophenolate Mofetil (CellCept).
- Biologic agents: Adalimumab (Humira) or Infliximab (Remicade), which are increasingly used for refractory cases of Pars Planitis.
- Intravitreal implants: Sustained-release dexamethasone implants (Ozurdex) for localized inflammation.
When is surgery considered for Pars Planitis?
Surgical intervention is generally reserved for complications resulting from chronic Pars Planitis, such as dense vitreous opacities or tractional retinal detachment. A pars plana vitrectomy is the most common procedure performed to clear inflammatory debris from the vitreous cavity. It is important to note that surgery is typically performed only after inflammation has been stabilized with medication.
Which specialists should be on my care team?
Managing Pars Planitis requires a multidisciplinary approach. Your care team should include a uveitis specialist (a sub-specialty of ophthalmology), a rheumatologist to manage systemic immunosuppression, and a pharmacist to monitor medication interactions. With 21 members currently sharing their experiences on DiseaseMaps.org, connecting with the community can provide valuable peer support during this journey.
Next steps
- Schedule a consultation with a fellowship-trained uveitis specialist.
- Keep a detailed log of your symptom flares and medication side effects.
- Join the Pars Planitis community at DiseaseMaps.org to connect with others managing this condition.
- Discuss the risks and benefits of biologic therapies with your ophthalmologist.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with your healthcare provider for personalized diagnosis and treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Intermediate Uveitis
- Orphanet: Pars planitis
- American Academy of Ophthalmology (AAO): Uveitis and Ocular Inflammation Guidelines
- PubMed: Current Management Strategies for Intermediate Uveitis
